{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26287872",
  "DateCompleted": {
    "Year": "2016",
    "Month": "05",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2015",
        "Month": "08",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e0134437",
      "10.1371/journal.pone.0134437"
    ],
    "Journal": {
      "ISSN": "1932-6203",
      "JournalIssue": {
        "Volume": "10",
        "Issue": "8",
        "PubDate": {
          "Year": "2015"
        }
      },
      "Title": "PloS one",
      "ISOAbbreviation": "PLoS One"
    },
    "ArticleTitle": "Monoacylglycerol Lipase Regulates Fever Response.",
    "Pagination": {
      "StartPage": "e0134437",
      "MedlinePgn": "e0134437"
    },
    "Abstract": {
      "AbstractText": [
        "Cyclooxygenase inhibitors such as ibuprofen have been used for decades to control fever through reducing the levels of the pyrogenic lipid transmitter prostaglandin E2 (PGE2). Historically, phospholipases have been considered to be the primary generator of the arachidonic acid (AA) precursor pool for generating PGE2 and other eicosanoids. However, recent studies have demonstrated that monoacyglycerol lipase (MAGL), through hydrolysis of the endocannabinoid 2-arachidonoylglycerol, provides a major source of AA for PGE2 synthesis in the mammalian brain under basal and neuroinflammatory states. We show here that either genetic or pharmacological ablation of MAGL leads to significantly reduced fever responses in both centrally or peripherally-administered lipopolysaccharide or interleukin-1\u03b2-induced fever models in mice. We also show that a cannabinoid CB1 receptor antagonist does not attenuate these anti-pyrogenic effects of MAGL inhibitors. Thus, much like traditional nonsteroidal anti-inflammatory drugs, MAGL inhibitors can control fever, but appear to do so through restricted control over prostaglandin production in the nervous system."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA, 92037, United States of America."
          }
        ],
        "LastName": "Sanchez-Alavez",
        "ForeName": "Manuel",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA, 92037, United States of America."
          }
        ],
        "LastName": "Nguyen",
        "ForeName": "William",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA, 92037, United States of America."
          }
        ],
        "LastName": "Mori",
        "ForeName": "Simone",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dipartimento di Scienze Cliniche e Molecolari, Universit\u00e0 Politecnica delle Marche, Ancona, Italy."
          }
        ],
        "LastName": "Moroncini",
        "ForeName": "Gianluca",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA, 92037, United States of America."
          }
        ],
        "LastName": "Viader",
        "ForeName": "Andreu",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, 94720, United States of America."
          }
        ],
        "LastName": "Nomura",
        "ForeName": "Daniel K",
        "Initials": "DK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA, 92037, United States of America."
          }
        ],
        "LastName": "Cravatt",
        "ForeName": "Benjamin F",
        "Initials": "BF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA, 92037, United States of America."
          }
        ],
        "LastName": "Conti",
        "ForeName": "Bruno",
        "Initials": "B"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 NS085155",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "K01 GM109315",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 DA032933",
        "Acronym": "DA",
        "Agency": "NIDA NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "DA032933",
        "Acronym": "DA",
        "Agency": "NIDA NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA172667",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "NS085155",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "CA172667",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "GM109315",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 GM113894",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS One",
    "NlmUniqueID": "101285081",
    "ISSNLinking": "1932-6203"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cannabinoid Receptor Modulators"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Enzyme Inhibitors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptor, Cannabinoid, CB1"
    },
    {
      "RegistryNumber": "EC 3.1.1.23",
      "NameOfSubstance": "Monoacylglycerol Lipases"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Body Temperature"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Cannabinoid Receptor Modulators"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Enzyme Inhibitors"
    },
    {
      "QualifierName": [
        "drug therapy",
        "enzymology",
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Deletion"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Monoacylglycerol Lipases"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors"
      ],
      "DescriptorName": "Receptor, Cannabinoid, CB1"
    }
  ],
  "CoiStatement": "<b>Competing Interests: </b>B.F.C. is a founder and advisor to Abide Therapeutics, a biotechnology company interested in developing serine hydrolase inhibitors and therapeutics. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials."
}